Patent · US Active

High-purity quinoline derivative and method for manufacturing same

US11186547B2 · kind B2 · utility

0Cited by
104References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2020
Grant dateNov 30, 2021
Priority date
Expiry dateSep 16, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/47
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a compound represented by formula (IV) or a salt thereof, wherein the content of the compound represented by formula (I) is 350 ppm by mass or less.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.